Pine Bridge Investments, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Pine Bridge Investments, L.P.

$13.1 Billion
Q3 2024

A detailed history of Pine Bridge Investments, L.P. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pine Bridge Investments, L.P. holds 26,705 shares of REGN stock, worth $19.9 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

26,705

Previous 29,255 8.72%

Holding current value

$19.9 Million

Previous $30.7 Million 8.7%

% of portfolio

0.21%

Previous 0.25%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1024.09 - $1201.76 $2.61 Million - $3.06 Million	-2,550 Reduced 8.72%	26,705 $28.1 Million
Q2 2024 Aug 14, 2024	SELL	$883.2 - $1071.19 $8.06 Million - $9.78 Million	-9,127 Reduced 23.78%	29,255 $30.7 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $2.49 Million - $2.73 Million	2,753 Added 7.73%	38,382 $36.9 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $486,037 - $552,825	-627 Reduced 1.73%	35,629 $31.3 Million
Q3 2023 Nov 14, 2023	BUY	$692.45 - $844.37 $3.91 Million - $4.76 Million	5,640 Added 18.42%	36,256 $29.8 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $14.7 Million - $17.4 Million	-20,956 Reduced 40.63%	30,616 $22 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $407,613 - $495,355	-599 Reduced 1.15%	51,572 $42.4 Million
Q4 2022 Feb 09, 2023	SELL	$705.89 - $766.39 $9.32 Million - $10.1 Million	-13,205 Reduced 20.2%	52,171 $37.6 Million
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $2.01 Million - $2.53 Million	-3,498 Reduced 5.08%	65,376 $45 Million
Q2 2022 Aug 05, 2022	BUY	$548.35 - $738.84 $26.1 Million - $35.2 Million	47,635 Added 224.28%	68,874 $40.7 Million
Q1 2022 May 12, 2022	BUY	$595.12 - $698.43 $2.09 Million - $2.45 Million	3,515 Added 19.83%	21,239 $14.8 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $9.63 Million - $11.9 Million	17,724 New	17,724 $11.2 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $56,263 - $66,466	-119 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $1.45 Million - $1.78 Million	-3,255 Reduced 96.47%	119 $56,000
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $7,174 - $9,119	-15 Reduced 0.44%	3,374 $1.63 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $2.47 Million - $2.98 Million	-4,528 Reduced 57.19%	3,389 $1.9 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $2.83 Million - $3.69 Million	5,728 Added 261.67%	7,917 $4.94 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $663,955 - $976,499	1,975 Added 922.9%	2,189 $1.07 Million
Q4 2019 Feb 13, 2020	SELL	$274.13 - $376.51 $1.17 Million - $1.6 Million	-4,259 Reduced 95.22%	214 $80,000
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $1.24 Million - $1.44 Million	-4,530 Reduced 50.32%	4,473 $1.24 Million
Q2 2019 Aug 13, 2019	BUY	$299.6 - $414.82 $2.7 Million - $3.73 Million	9,003 New	9,003 $2.82 Million
Q1 2019 May 14, 2019	SELL	$372.08 - $439.57 $2.63 Million - $3.1 Million	-7,057 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$335.82 - $403.04 $1.27 Million - $1.52 Million	3,776 Added 115.09%	7,057 $2.64 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $1.15 Million - $1.34 Million	3,281 New	3,281 $1.33 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $12,316 - $15,357	-39 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $1,793 - $2,349	5 Added 14.71%	39 $15,000
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $3,882 - $4,536	9 Added 36.0%	34 $15,000
Q2 2017 Aug 11, 2017	BUY	N/A	25	25 $12,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Pine Bridge Investments, L.P. with notifications on news.

Account

Pine Bridge Investments, L.P. Regeneron Pharmaceuticals, Inc. Transaction History